COPD mortality risk minimized by inhaled corticosteroidsAccording to a study, a significantly reduced mortality risk may be seen in patients with chronic obstructive pulmonary disease (COPD) and using inhaled corticosteroids.

It was shown by the research that patients receiving inhaled corticosteroids within 30 days of hospital discharge had a twenty-five percent minimized all-cause mortality rate while numbers of cardiovascular-pertaining death alone in patients using steroids paired with beta-agonist were reduced by thirty-eight percent.

Author Christine Macie, MD, FCCP, Cambridge Hospital, Ontario, Canada, remarked that this study analyzed the effect of inhaled corticosteroids on survival and the study results suggest that survival is longer in patients using inhaled corticosteroids.